Source: Sharecast
AstraZeneca gained after saying that its Imfinzi asset has been approved in the EU as the first and only perioperative immunotherapy for muscle-invasive bladder cancer.
Housebuilder Barratt Redrow was in the red after MJ Gleeson delivered a cautious outlook. The low-cost, affordable housebuilder said the housing market "lacks confidence and remains subdued".
"The board does not see a short-term catalyst for any substantial improvement," it said.
FTSE 100 - Risers
Vodafone Group (VOD) 81.76p 3.18%
Fresnillo (FRES) 1,484.00p 1.64%
Coca-Cola HBC AG (CDI) (CCH) 4,012.00p 1.21%
Coca-Cola Europacific Partners (DI) (CCEP) 7,040.00p 0.72%
AstraZeneca (AZN) 10,270.00p 0.65%
Centrica (CNA) 159.30p 0.63%
Rolls-Royce Holdings (RR.) 960.40p 0.63%
Haleon (HLN) 375.10p 0.54%
GSK (GSK) 1,400.50p 0.47%
Associated British Foods (ABF) 2,081.00p 0.43%
FTSE 100 - Fallers
Smurfit Westrock (DI) (SWR) 3,411.00p -2.46%
Mondi (MNDI) 1,199.00p -2.32%
Schroders (SDR) 363.40p -2.05%
Airtel Africa (AAF) 178.60p -1.92%
Intermediate Capital Group (ICG) 1,923.00p -1.89%
Barratt Redrow (BTRW) 425.80p -1.84%
Croda International (CRDA) 2,993.00p -1.77%
Babcock International Group (BAB) 1,067.00p -1.75%
Anglo American (AAL) 2,205.00p -1.74%
easyJet (EZJ) 522.80p -1.66%